Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
Open in App
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
IPO
Alerts
About
Gland Pharma Ltd.
NSE: GLAND
|
BSE: 543245
|
ISIN: INE068V01023
|
Industry: Pharmaceuticals
US FDA Observation
|
Mid-range Performer
2843.9000
17.10
(
0.60
%)
NSE
Oct 26, 2026
15:31 PM
80.73% Gain from 52W Low
Volume:
480.6K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Gland Pharma Ltd.
06 Aug 2025
US FDA Observation
2843.90
0.60%
Result Update:Gland Pharma
Hold:
Gland Pharma Ltd.
by
Axis Direct
Target: 1950
Target
Axis Direct
We maintain our HOLD rating on the stock with a target price of Rs 1,950/share.
Gland Pharma has gained
46.49%
in the last 1 Year
More from Gland Pharma Ltd.
Recommended
Primary market awaits Jio Platforms' listing as nine new issues enter the pipeline
|
26 Oct 2026, 05:33PM
Market closes higher, led by IT and financial stocks
Trendlyne Marketwatch |
26 Oct 2026, 04:02PM
Gland Pharma IPO: A Chinese-owned pharmaceutical company hits the IPO market
|
12 Nov 2020